This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Trummel, C.L. Search for Related Content PubMed PubMed Citation Articles by Trummel, C.L. Social Bookmarking                         What's this?

Regulation of Oral Chemotherapeutic Products in the United States

Department of Periodontology, School of Dental Medicine, University of Connecticut Health Center, Farmington, CT 06030

Although many countries have well-established mechanisms for regulation of drugs dispensed by prescription order, far less attention has been directed to control of drugs sold "over-the-counter" (OTC). Since most oral chemotherapeutic agents are OTC preparations, these drugs frequently escape critical review of their safety and efficacy by regulatory agencies. Although widespread use of these OTC preparations indicates that they are generally safe, their effectiveness is not established. In some cases (e.g., detergent pre-brush rinses), there is good evidence for lack of efficacy. In the US, two recent developments suggest that more rigorous scientific review and oversight of oral chemotherapeutic agents will occur. First, the US Food & Drug Administration has initiated a process to evaluate several OTC products which claim to be effective against plaque and gingivitis. A panel of experts has been convened to establish criteria by which these products will be judged and regulated. The agency has also publicly indicated its intention to interact more closely with the dental community in discharging its responsibility for ensuring drug safety and eff icacy. Second, the American Dental Association, through its Council on Dental Therapeutics, is refining criteria for evaluating various types of chemotherapeutic agents. These criteria will be used to judge the efficacy and safety of agents voluntarily submitted for review to the Council by manufacturers. Both of these developmentsshould improve the clinical utility of suchagents and may provide models for regulatory agencies in other countries.

Key Words: Drug Regulation • Drug Safety • Efficacy.

Journal of Dental Research, Vol. 73, No. 3, 704-708 (1994)
DOI: 10.1177/00220345940730031701


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?